About
Technology
Issues
FAQ
Links
Official Page
Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected Individuals
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.